Heterozygous knock-in mouse models carrying the dominant negative PPARγ mutations L466A and P465L, which were found in humans with lipodystrophy and/or the metabolic syndrome, recapitulated some of the features of the human phenotypes. Here, PPARG is linked to lipodystrophy.